Biol stock forecast.

According to Biolase 's latest financial reports and stock price the company's current number of shares outstanding is 1,179,000. At the end of 2023 the ...

Biol stock forecast. Things To Know About Biol stock forecast.

Brickell Biotech, Inc. (NASDAQ:BBI) released its quarterly earnings data on Thursday, August, 11th. The company reported ($0.01) EPS for the quarter, topping the consensus estimate of ($1.48) by $1.47. Brickell Biotech had a negative trailing twelve-month return on equity of 156.10% and a negative net margin of 643.48%.Find real-time NIO - NIO Inc stock quotes, company profile, news and forecasts from CNN Business.Real time Biolase (BIOL) stock price quote, stock graph, news & analysis. Based on 4 Wall Street analysts offering 12 month price targets for Tempest Therapeutics in the last 3 months. The average price target is $21.67 with a high forecast of $47.00 and a low forecast of $8.00. The average price target represents a 452.81% change from the last price of $3.92. Highest Price Target $47.00. Average Price Target $21.67.

Price Target. Based on short-term price targets offered by three analysts, the average price target for Biolase comes to $15.67. The forecasts range from a low of $3.00 to a high of $40.00. The ...

Find the latest Leap Therapeutics, Inc. (LPTX) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W ...Based on 4 Wall Street analysts offering 12 month price targets for Tempest Therapeutics in the last 3 months. The average price target is $21.67 with a high forecast of $47.00 and a low forecast of $8.00. The average price target represents a 452.81% change from the last price of $3.92. Highest Price Target $47.00. Average Price Target $21.67.

BIOL N/A N/A Short Interest (10/31/23) Shares Sold Short 8,569 Change from Last -70.26% Percent of Float 0.43% Stock Money Flow N/A Research & Ratings Biolase Inc. Per …The current average BIOL price target, as estimated by these analysts, is $0.00. The predictions for the future BIOL stock price range from a low of $0.00 to a high of $0.00, highlighting the variability of market expectations for BIOL. Stock Forecast Currrency forecast Cryptocurrency forecast Blog All stock predictions Overall outlook for BIOLASE stock Tomorrow Week Month 2023 2024 2025 2026 2027 …BIOL Stock Analysis Overview What this means: InvestorsObserver gives Biolase Inc (BIOL) an overall rank of 34, which is below average. Biolase Inc is in the bottom half of …

Stock Price Forecast. The 3 analysts offering 12-month price forecasts for BIOLASE Inc have a median target of 3.00, with a high estimate of 40.00 and a low estimate of 2.50. The median estimate represents a +143.90% increase from the last price of 1.23.

BIOL Stock Forecast, Price & News (BIOLASE) - MarketBeat WebJan 13, 2023 · About BIOLASE (NASDAQ:BIOL) Stock BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally.

Jul 19, 2021 · Starting us off today is Twist Biosciences. In brief, Twist is a leading name in the synthetic biology industry today. The company’s core work revolves around its proprietary DNA synthesis ... Nov 21, 2023 · BIOLASE stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for BIOLASE analysts is $ 21.38 . Today 200 Day Moving Average is the resistance level ( 15.93 $). The firm earned $10.92 million during the quarter. BIOLASE has generated ($158.82) earnings per share over the last year ( ($158.82) diluted earnings per share). BIOLASE has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 26th, 2024 based off prior year's report dates.GEVO Stock 12 Months Forecast. $6.47. (528.16% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Gevo in the last 3 months. The average price target is $6.47 with a high forecast of $14.00 and a low forecast of $2.00. The average price target represents a 528.16% change from the last price of $1.03.Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...Nov 27, 2023 · CEO. Website. 1984. 190. John Beaver. https://www.biolase.com. BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists ...

Find the latest Bio-Rad Laboratories, Inc. (BIO) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W ...Find the latest BioLargo, Inc. (BLGO) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...Stock analysis for Biolase Inc (BIOL:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. BIOL: BIOLASE Inc - Stock Price, Quote and News - CNBCPenny Stocks To Buy [according to analysts]: Biolase Inc. Looking at the chart of Biolase Inc. (BIOL Stock Forecast), we can see a starkly different trend in comparison to the AMPE stock chart.Sure, this year has been relatively flat. But pull out a 2-year chart and you’ll see that BIOL stock has been in a perpetual downtrend since last …Molecular Biology of Life. An intensive introductory lecture course covering the cell, molecular biology, biochemistry, and the genetics of animals, bacteria, and viruses. This course is comparable to Biology 1101, but places greater emphasis on molecular mechanisms and experimental approaches. BIOL Stock Forecast, Price & News …

At just 47 cents a share, BIOL stock is in danger of being delisted by the Nasdaq, which requires companies to maintain a minimum share price of $1 to remain on the exchange. However, in a news ...There was a snowstorm in the Northeast this week. Or maybe that supposed storm was just a light dusting. It depends on who you ask. Having grown up in the mountains of Colorado, I am well aware at just how terrible these forecasts tend to b...

6 analysts have issued 1-year price targets for Caribou Biosciences' shares. Their CRBU share price targets range from $13.00 to $32.00. On average, they predict the company's stock price to reach $23.57 in the next twelve months. This suggests a possible upside of 295.5% from the stock's current price. View analysts price targets for CRBU or ...BIOLASE Stock Forecast 23 Nov. Presumably, on 11/23/2023, the price of shares will be in the range of $1.42 - $1.48. A $0.07 range width can provide 4.64% volatility. The weighted average price of this range is at $1.44, which is $0.00 lower than the previous day's weighted average price.Find real-time BIO - Bio Rad Laboratories Inc stock quotes, company profile, news and forecasts from CNN Business. Based on 5 Wall Street analysts offering 12 month price targets for Cleanspark in the last 3 months. The average price target is $9.16 with a high forecast of $14.00 and a low forecast of $5.30. The average price target represents a 123.96% change from the last price of $4.09. Highest Price Target $14.00. Average Price Target $9.16.BIOL Stock Analysis Overview What this means: InvestorsObserver gives Biolase Inc (BIOL) an overall rank of 34, which is below average. Biolase Inc is in the bottom half of …Find the latest ImmunityBio, Inc. (IBRX) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...Find the latest BioLife Sciences Inc. (BLFE) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...Zymergen, which describes itself as a “biofacturing company using biology to reimagine the world,” plunged 68% in extended trading on Tuesday to $11.07, down from its IPO price of $31. The ...Find the latest Biora Therapeutics, Inc. (BIOR) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W ...NASDAQ Health Care/Life Sciences Compare to Open 1.27 Prior Close 1.22 (11/22/23) 1 Day BIOL 1.64% DJIA 0.33% Russell 2K 0.67% Health Care/Life Sciences 0.32% …

For Biolase Inc Stock (BIOL) price forecast for 2024, the average price target for Biolase Inc Stock is $21.75 with a high forecast of $42.41 and a low forecast of $1.0934. The average BIOL price prediction of 2024 represents a +1,639% increase from the last price of $1.2506.

Biolase, Inc. (BIOL) stock forecast and price target. Find the latest Biolase, Inc. BIOL analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.

Find the latest Financials data for Biolase, Inc. Common Stock (BIOL) at Nasdaq.com.BIOL- running earnings 8/10 LONG BIOL had a triple top in late July so this is a logical long target at 8,0, With earnings in less than two days, volumes above the mean in the past couple of days and a decent price-volume product trend coupled with a Price Monetum Oscillator without any signs of topping out in a momentum stall BIOL had a triple top in late July so this is a logical long target ... 218.18%. Free cash flow. Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments. -55.91M. 21.33%. Get the latest Immunitybio Inc (IBRX) real ...Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants PR Newswire - Wed Sep 13, 10:16PM CDT. /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten... The bad news for investors in BIOL stock is the company’s earnings per share of -18 cents for the period. That’s worse than Wall Street’s estimate of -10 cents for the quarter. However, it ...Find the latest T2 Biosystems, Inc. (TTOO) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...Quotes Summary Real-Time After-Hours Key Data Bid Price and Ask Price The bid & ask refers to the price that an investor is willing to buy or sell a stock. The bid is the highest …The 12-month stock price forecast is $113.33, which is an increase of 9,594.61% from the latest price. Price Target ( 9,594.61% upside) Analyst Consensus: Strong Buy News All Videos Press Releases ConversationBIOL Stock Forecast, Price & News (BIOLASE) - MarketBeat WebJan 13, 2023 · Their BIOL share price forecasts range from $5.00 to $14.00. On average, they anticipate the company's share price to reach $9.50 in the next year. This suggests a possible upside of 2,251.5% fromFind the latest Intelligent Bio Solutions Inc. (INBS) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term ...BIOL's price to book (P/B) is 81% more than its last 4 quarters average of 2.0 but 38% less than its 5-year quarterly average of 5.8 The stock's price to sales (P/S) is 97% less than its 5-year quarterly average of 1.0 and 70% less than its last 4 quarters average of 0.1

Artificial Intelligence Technology Solutions saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 75,400 shares, an increase of 2,692.6% from the October 15th total of 2,700 shares. Based on an average trading volume of 72,060,200 shares, the short-interest ratio is currently 0.0 days.Their UBX share price targets range from $4.00 to $10.00. On average, they anticipate the company's share price to reach $6.50 in the next twelve months. This suggests a possible upside of 226.6% from the stock's current price. View analysts price targets for UBX or view top-rated stocks among Wall Street analysts.218.18%. Free cash flow. Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments. -55.91M. 21.33%. Get the latest Immunitybio Inc (IBRX) real ...Instagram:https://instagram. ixjamazon wall street journalwhats an sec filingiphone 14 pro max sold out BIOLASE Stock Forecast 11-30-2023. Forecast target price for 11-30-2023: $ 1.19. Negative dynamics for BIOLASE shares will prevail with possible volatility of 4.961%. Pessimistic target level: 1.17. Optimistic target level: 1.23. etf oil and gasfutures brokers list Request PDF | Levine JM, D'Antonio CM. Forecasting biological invasions with increasing international trade. Conserv Biol ... Key message This study takes stock ...Among DNA stocks, Twist Bioscience (NASDQ: TWST) stands above the rest in terms of price. It offers to sell DNA at a cost as low as 7 cents per base pair, far below competitors like Genscript ... treasury yield 20 years allforecast.comHigh Growth Earnings: BIOL is forecast to remain unprofitable over the next 3 years. Revenue vs Market: BIOL's revenue (10% per year) is forecast to grow faster than the US market (8% per year). High Growth Revenue: BIOL's revenue (10% per year) is forecast to grow slower than 20% per year.